Vitamin D3 for Life

Live Enlightened

Physiology

Maternal Vitamin D Adaptations During Pregnancy: Study Summary

Previous related pageMaternal Vitamin D Adaptations During Pregnancy: Full Evidence ReviewNext related pagePharmacokinetics of a single, large dose of cholecalciferol: Full Study
Study at a glance

What was the question?

How do vitamin D measurements change during pregnancy? The review separates 25-hydroxyvitamin D, the usual blood marker, from calcitriol, the active hormone, and the proteins that carry vitamin D.

Who was studied?

Seven investigations studied pregnant adults and adolescents. Some followed the same people over time. Others compared different people at different pregnancy stages. One trial assigned different vitamin D3 supplement amounts.

What did the studies find?

Active-hormone concentrations were higher in a small early study. The usual status marker rose in some groups and fell in another. Season and other differences affected interpretation. A study of 58 adolescents found no significant average change in directly measured free 25-hydroxyvitamin D between entry and delivery. Free means the amount not attached to carrier proteins.

What does this mean?

Different vitamin D measurements cannot be treated as one result. Calculated free amounts are not the same as direct measurements. Supplements changed blood status, but this did not establish a guaranteed health benefit. The studies do not prove one universal pregnancy pattern, personal blood target or supplement dose.

Read the full article below ↓

Pregnancy can change several vitamin D measurements in different ways. A rise in the active hormone does not mean that every vitamin D blood measurement has risen. Seven human studies help explain these changes, but they do not establish one ideal blood level or supplement dose for everyone. The detailed methods, findings and limits are in Maternal Vitamin D Adaptations During Pregnancy: Full Evidence Review.

What was studied?

The studies examined pregnant adults and adolescents. Some followed the same people over time. Others compared different people at different stages of pregnancy. One trial randomly assigned different vitamin D3 supplement amounts. These designs answer different questions: observing a change is not the same as proving what caused it.

The usual status marker is 25-hydroxyvitamin D. The active hormone is 1,25-dihydroxyvitamin D, also called calcitriol. They are different substances. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D explains why their blood concentrations cannot be read as if they were the same test.

What changed during pregnancy?

An older, small study found higher active-hormone concentrations in pregnancy. However, it did not show whether greater production or slower removal caused the difference. Most participants were measured once, so the comparison did not establish one pattern that every individual follows.

Studies of the usual status marker found different patterns. Mean concentrations rose during pregnancy in selected Swedish and Colombian groups. They fell in a small Irish group whose babies were born in winter. Season, supplements and the people studied affected interpretation. These results do not prove that pregnancy alone always raises or always lowers vitamin D status.

Why do carrier proteins matter?

Most vitamin D-related substances in blood are attached to proteins. The small amount that is not attached is called the free fraction. Vitamin D Transport Proteins explains these carriers. A total measurement includes both attached and unattached material.

In one study, researchers calculated the free fraction from other measurements. The calculated free status marker was lower at later pregnancy stages. In a separate study of 58 adolescents, researchers measured the free fraction directly. Its average concentration did not change significantly between entry and delivery, even though carrier concentrations changed.

These findings are not interchangeable. A calculation depends on assumptions about binding. A direct test has its own measurement limits. Free Versus Total Vitamin D Measurement and Interpretation: Full Study explains the difference. Neither pregnancy study proved that a free test is better for predicting every health outcome. The adolescent study also found that active-hormone concentrations did not simply rise steadily through delivery.

What did supplementation establish?

The Hollis trial found that assigned vitamin D3 supplements changed the usual status-marker concentration. Higher exposure helped more participants reach the study’s specified blood threshold. That threshold was a research definition, not a personal target established by this review.

The trial did not demonstrate significant differences in gestational age, birthweight or higher-level neonatal care. Many participants did not complete follow-up, and the main question concerned blood measurements. The study therefore cannot establish either a guaranteed health benefit or the absence of every possible benefit. Research supplement amounts are not instructions for pregnancy care.

What does this mean?

Pregnancy-related vitamin D physiology is more complex than one number moving up or down. The substance measured, the laboratory method, carrier proteins, stage of pregnancy and time of year all matter. Adult and adolescent findings also may not apply in the same way to every population.

A higher active-hormone concentration does not establish its cause. A changed status marker does not by itself show improved maternal or infant health. The evidence supports careful interpretation of the different measurements, while leaving uncertainty about causal mechanisms and the best clinical use of free measurements.

Sources and access

This Summary uses the same seven assessed investigations as its Full Evidence Review. It adds no new evidence. The full review explains source versions, the Hollis correction and claims excluded because material was unavailable.

Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. Kumar R et al. Journal of Clinical Investigation. 1979;63:342 to 344.

Opposite correlation of 25-hydroxy-vitamin D: and 1,25-dihydroxy-vitamin D-metabolites with gestational age, bone: and lipid-biomarkers in pregnant women. Tsuprykov O et al. Scientific Reports. 2021;11:1923.

Longitudinal Changes in Serum Vitamin D Binding Protein and Free 25-hydroxyvitamin D in a Multiracial Cohort of Pregnant Adolescents. Best CM et al. Journal of Steroid Biochemistry and Molecular Biology. 2019;186:79 to 88.

Vitamin D Status during Pregnancy: A Longitudinal Study in Swedish Women from Early Pregnancy to Seven Months Postpartum. Lundqvist A et al. PLOS ONE. 2016;11:e0150385.

Impact of pregnancy on vitamin D status: a longitudinal study. Zhang JY et al. British Journal of Nutrition. 2014;112:1081 to 1087.

Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women. Agudelo-Zapata Y et al. Endocrine Connections. 2018;7:698 to 707.

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. Hollis BW et al. Journal of Bone and Mineral Research. 2011;26:2341 to 2357. Correction: Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. 2011.

Related reading

Library

Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy

The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.

Original paper ↗Read more →

Original sources

Source

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness

Published in Hollis BW et al. Journal of Bone and Mineral Research (2011).

Publication details

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. Hollis BW et al. Journal of Bone and Mineral Research. 2011;26:2341 to 2357. Correction: Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. 2011.

Read more →
Source

Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness.

Publication details

Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. Hollis BW et al. Journal of Bone and Mineral Research. 2011;26:2341 to 2357. Correction: Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. 2011.

Read more →